Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
2019
A consolidated overview of evidence for the effectiveness and safety/tolerability of hepatic encephalopathy (HE) treatment over the long term is currently lacking. We identified and assessed published evidence for the long-term (≥6 months) pharmacological management of HE with lactulose and/or rifax
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
51
References
25
Citations
NaN
KQI